Concomitant (concurrent) chemoradiotherapy vs radical surgery
Overall survival (5‐year) · women (18 years and older) diagnosed with stage IB2 cervical cancer
1 finding from 1 review
- Type II or type III radical hysterectomy compared to chemoradiotherapy as a primary intervention for stage IB2… 2018 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedVery low